欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号
DE/H/0040/002
药品名称
Hivid Roche 0.75 mg
活性成分
Zalcitabine 750.0 µg
剂型
Film-coated tablet
上市许可持有人
Hoffmann-La Roche AG Emil-Barell-Str. 1 D-79639 Grenzach-Wyhlen
参考成员国 - 产品名称
Germany (DE)
互认成员国 - 产品名称
Denmark (DK)
Hivid Roche 0.75
Belgium (BE)
Hivid Roche 0.375
Luxembourg (LU)
Hivid Roche 0.375
United Kingdom (Northern Ireland) (XI)
Hivid Roche 0.375
Ireland (IE)
Hivid Roche 0.375
France (FR)
Hivid Roche 0.375
Portugal (PT)
Hivid Roche 0.375
Italy (IT)
Hivid Roche 0.375
Greece (GR)
Hivid Roche 0.375
Sweden (SE)
Hivid Roche 0.75
Finland (FI)
Hivid Roche 0.75
许可日期
2008/04/05
最近更新日期
2024/12/12
药物ATC编码
J ANTIINFECTIVES FOR SYSTEMIC USE
J05 ANTIVIRALS FOR SYSTEMIC USE
J05A DIRECT ACTING ANTIVIRALS
J05AF Nucleoside and nucleotide reverse transcriptase inhibitors
J05AF03 zalcitabine
申请类型
TypeLevel1:
[not specified]
TypeLevel2:
[not specified]
TypeLevel3:
[not specified]
TypeLevel4:
[not specified]
TypeLevel5:
[not specified]
附件文件下载
市场状态
Positive
©2006-2025
Drugfuture
->
European Union HMA Authorisation of Medicines DataBase